期刊文献+

原发性高血压与高同型半胱氨酸血症的临床分析 被引量:3

Clinical Analysis on Essential Hypertension and Hyperhomocysteinemia
下载PDF
导出
摘要 目的探讨原发性高血压与高同型半胱氨酸(hHcy)血症的关系。方法随机选择原发性高血压患者中109例高同型半胱氨酸血症者测定血脂、血糖、肾功能及血清同型半胱氨酸(Hcy)、叶酸、维生素B12水平,部分行冠状动脉造影术和头颅MR I或CT、分为4组:单纯原发性高血压组(Ⅰ组,n=26)、原发性高血压伴冠心病组(Ⅱ组,n=29)、原发性高血压伴脑梗塞组(Ⅲ组,n=22)、原发性高血压伴2型糖尿病(同时合并冠心病或/和脑梗塞)组(Ⅳ组,n=32),进行各项参数对比分析。结果收缩压、总胆固醇、高密度脂蛋白、低密度脂蛋白、脂蛋白(a)、肌酐各组比较差异无显著性(P>0.05),叶酸水平Ⅲ组<Ⅳ组<Ⅱ组<Ⅰ组,Ⅲ组与Ⅰ组对比差异有显著性(P<0.05),维生素B12水平Ⅳ组<Ⅱ组<Ⅲ组<Ⅰ组,Ⅳ组和Ⅱ组较Ⅰ组对比差异有显著性(P<0.01),Hcy水平Ⅲ组>Ⅱ组>Ⅳ组>Ⅰ组,差异无显著性(P>0.05);多元线性回归分析表明,年龄是原发性高血压患者Hcy影响因素(β=0.202,P<0.05),hHcy与收缩压和舒张压无关(SBP:r=0.035,P=0.734;DBP,r=0.076,P=0.457)。结论高同型半胱氨酸血症是原发性高血压的独立危险因素。单纯原发性高血压叶酸、维生素B12相对较高,原发性高血压并冠心病、脑梗塞、糖尿病时,叶酸、维生素B12下降程度不一样。
出处 《现代诊断与治疗》 CAS 2005年第6期332-333,共2页 Modern Diagnosis and Treatment
  • 相关文献

参考文献9

  • 1Boushey CJ. A quantitative assessment of plasma homocysteine as a risk factor for vascular disaese[J] . JAMA,1995,274:1049-1057.
  • 2Perry IJ,Refsum H,Morris RW,et al. Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men [J]. Lancet, 1995,346:1359-1398.
  • 3Markus HS, Ali N, Swarminathan R, et al. A common polymorphism in the methylenetetrahydrofolate reductase gene, homocysteine, and ischemic cerebrovacular disease[J]. Stroke, 1997,28:1739-1743.
  • 4林小慧,李娜,董玉娟.同型半胱氨酸及其代谢酶基因多态性与动脉粥样硬化和脑梗死[J].国外医学(脑血管疾病分册),2004,12(5):367-370. 被引量:13
  • 5梁伟,赵列宾,王巍,杜萱,苏莉珍,陆骆,陈名道,沈倍倍.2型糖尿病合并冠心病患者血清同型半胱氨酸水平的研究[J].中华内分泌代谢杂志,2002,18(4):311-312. 被引量:48
  • 6Malinow MR, Kang SS, Taylor LM, et al. Prevalence of hyperhomocy-sti naemia in patients with perpheral arterial occlusive disease[ J]. Circulation, 1989,79:1180-1188.
  • 7Sutton-Tyrrell K, Bostom A, Selhub J, et al. High homocysteine levels are independently related to isolated systolic hypertension in older adults[J].Circulation, 1997,96:1745-1749.
  • 8詹思延,高原原,尹香君,黄玉婵,胡永华,李立明.同型半胱氨酸代谢异常与原发性高血压的病例对照研究[J].中华流行病学杂志,2000,21(3):194-197. 被引量:24
  • 9Rasmussen K,Moller J,Lyngbak M,et al. Age and gender-specific reference intervals for total homocystieine and methylmalonic acid in plasma before and after vitamin supplementation [J]. Clin Chem, 1996,42: 630-636.

二级参考文献38

  • 1李光伟,Step.,L.检测人群胰岛素敏感性的一项新指数[J].中华内科杂志,1993,32(10):656-660. 被引量:2125
  • 2Imueller T, Furtmueller B, Aigelsdorfer J, et al. Total serum homocysteine-a predictor of extracranial carotid artery stenosis in male patients with symptomatic peripheral arterial disease. Vasc Med, 2001,6:163 - 167.
  • 3McQuillan BM, Beilby JP, Nidorf M, et al. Hyperhomocysteinemia but not the C677T mutation of methylenetetrohydrofolate reductase is an independent risk determinant of carotid wall thickening. Circulation,1999, 99:2383 -2388.
  • 4Southern F, Edit J, Drouilbet J, et al. Increasing levels of dietary homocysteine with carotid endarterectomy produced proportio-nate increase in plasma homocysteine and intimal hyperplasia. Atherosclerosis, 2001, 158:129 - 138.
  • 5Chen J, Stampfer MJ, Ma J, et al. Influence of a methionine synthase (D919G) polymorphism on plasma homocysteine and folate levels and relation to risk of myocardial infarction. Atherosclerosis, 2001, 154:667 - 672.
  • 6Hackam DG, Peterson JC, Spence JD. What level of plasma homocysteine should be treated? Effects of vitamin therapy on progression of carotid atherosclerosis in patients with homocysteine levels above and below 14 umol/L. Am J Hypertens, 2000, 13:105 -110.
  • 7Guenther BD, Shepparl CA, Tran P, et al. The structure and properties of methylenetetrahydrofolate reductase from Escherichia coli suggest how folate ameliorates human hyperhomocysteinemia. Nat Struct Biol, 1999, 6:359 -365.
  • 8The VITAOPS Trial Srudy Group. The VITATOPS(Vitamins to Prevent Stroke)Trial: rationale and design of an international, large, simple, randomized trial of homocysteine-lowering multivatamin therapy in patients with recent transient ischemic attack or stro
  • 9Friedman G, Goldschmidt N, Friedlander Y, et al. A common mutation A1298C in human methylenetetra hydrofolate reductase gene: association with plasma total homocysteine and folate concentrations. J Nutr, 1999, 129:1656 - 1661.
  • 10Tsai MY, Yang F, Bignell M, et al. Relation between plasma homocysteine concentration,the 844ins 68 variant of the cystathionine β-synthase gene,and pridoxal-5′-phosphate concentration. Mol Genet Metab,1999, 67:352 -356.

共引文献81

同被引文献52

  • 1张志民,曾红莲,廖俊,黄劼.H型高血压脑梗死与非H型高血压脑梗死相关因素分析[J].四川医学,2012,33(11):1913-1914. 被引量:8
  • 2张晓琳,黄文.高血压病中医病证及其体质规律研究进展[J].云南中医学院学报,2004,27(2):55-57. 被引量:2
  • 3符璇芝,颜登幼,崔秀涛.彩色多普勒超声检测肾内动脉对早期高血压肾病的诊断价值[J].中国超声诊断杂志,2005,6(5):382-383. 被引量:8
  • 4李卫丽,景光光,陈孝银.高同型半胱氨酸血症的中医病因病机探讨[J].辽宁中医杂志,2006,33(4):412-413. 被引量:52
  • 5Splendiani G, Parolini C, Fortunato L, et ah Resistive index in chronic nephropathies: predictive value of renal outcome. Clin Nephrol, 2002,57 : 45-50.
  • 6Lim U,Cassano PA. Homocysteine and blood pressure in the Third National Health and Nutrition Examination Survey, 1998-1994. Am J Epidemiol,2002,156:1105-1113.
  • 7Gettesater A, Anwaar I, Eriksson KF, et al. Homocysteine is related to neopterin and endothelin-1 in plasama of subjects with disturbed glucose metabolism and reference subjects. Angiology,2000,51:489- 497.
  • 8Van der Griend R, Biesma DH, Banga JD. Hyperhomocysteinaemia as a cardiovascular risk factor:an update. Neth J Med,2000,56:119-130.
  • 9Lim U, Cassano PA. Hornocysteine and blood pressure in the third National Health and Nutrition Examination Survey, 1998 -1994[J]. Am J Epidemiol, 2002, 156(12): 1105.
  • 10Gettesater A, Anwaar I, Eriksson KF, et al. Homocysteine is related to neopterin and endothelin - 1 in plasama of subjects with disturbed glucose metabolism and reference subjects[J]. Angiology, 2000, 51(6): 489.

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部